According to Hepion Pharmaceuticals's latest financial reports the company has $14.78 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $51.18 M | -43.96% |
2021-12-31 | $91.34 M | 124.3% |
2020-12-31 | $40.72 M | 192.52% |
2019-12-31 | $13.92 M | 391.56% |
2018-12-31 | $2.83 M | |
2017-06-30 | $12.98 M | 75.35% |
2016-06-30 | $7.4 M | 62.25% |
2015-06-30 | $4.56 M | 151.03% |
2014-06-30 | $1.81 M | 1996.22% |
2013-06-30 | $0.08 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.20 B | 1,308.01% | ๐บ๐ธ USA |